Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin vs Meglumine Antimoniate for Cutaneous Leishmaniasis
NCT00682656Phase 3Terminated
- Start
- Jun 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of azithromycin in cutaneous leishmaniasis (CL) (2 arms). Primary endpoint: Proportion of clinically cured patients at 3 months. Started Jun 2008; status: terminated.
02
Drugs
azithromycin
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00682656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00682656.